The current GATK version is 3.7-0
Examples: Monday, today, last week, Mar 26, 3/26/04

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Get notifications!


You can opt in to receive email notifications, for example when your questions get answered or when there are new announcements, by following the instructions given here.

Formatting tip!


Wrap blocks of code, error messages and BAM/VCF snippets--especially content with hashes (#)--with lines with three backticks ( ``` ) each to make a code block as demonstrated here.

Jump to another community
Picard 2.9.0 is now available. Download and read release notes here.
GATK 3.7 is here! Be sure to read the Version Highlights and optionally the full Release Notes.

New team member to help with GATK + Cancer Tools outreach & support

Geraldine_VdAuweraGeraldine_VdAuwera Cambridge, MAMember, Administrator, Broadie Posts: 11,662 admin

I'm very happy to introduce Sheila Chandran, our newest GSA team member, who will be helping me with GATK outreach, support and documentation. You can expect to see Sheila start answering questions on the GATK forum within a week or two!

Thanks to Sheila's help, I'll be able to expand our support model to the Broad Cancer Tools (MuTect and related). Moving forward, we'll produce documentation for MuTect and other tools produced by the Cancer Group in collaboration with the developers, in order to bring you the same level of documentation coverage and support that we currently have for GATK.

Rest assured however that we won't stop working on improving the GATK documentation. In fact, Sheila's first project with us will be to document how the HaplotypeCaller works in detail -- something I know many of you have been hoping to see for a while now!

As a final note, I'd like to mention that this is one of many positive outcomes from our collaboration with our commercial licensing partner, Appistry, so we'd like to express our thanks to them for helping us help you, our user community.

Geraldine Van der Auwera, PhD

Tagged:
Sign In or Register to comment.